Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$108.42 - $129.58 $6.94 Million - $8.29 Million
-64,000 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$115.43 - $146.63 $2.31 Million - $2.93 Million
-20,000 Reduced 23.81%
64,000 $8.13 Million
Q3 2021

Oct 14, 2021

BUY
$136.35 - $158.76 $136,350 - $158,760
1,000 Added 1.2%
84,000 $12.3 Million
Q4 2020

Feb 10, 2021

SELL
$128.25 - $151.41 $897,750 - $1.06 Million
-7,000 Reduced 7.78%
83,000 $12.8 Million
Q2 2020

Aug 10, 2020

SELL
$87.02 - $133.4 $261,060 - $400,200
-3,000 Reduced 3.23%
90,000 $10.7 Million
Q1 2020

May 08, 2020

BUY
$78.28 - $155.73 $469,680 - $934,379
6,000 Added 6.9%
93,000 $9.35 Million
Q2 2018

Aug 10, 2018

BUY
$102.12 - $114.04 $1.12 Million - $1.25 Million
11,000 Added 14.47%
87,000 $9.64 Million
Q4 2017

Aug 10, 2018

BUY
$105.55 - $120.83 $8.02 Million - $9.18 Million
76,000
76,000 $9.11 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.6B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track North Growth Management Ltd. Portfolio

Follow North Growth Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Growth Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on North Growth Management Ltd. with notifications on news.